home / stock / vxllf / vxllf news
Not for distribution to United States newswire services or for release publication, distribution or dissemination directly, or indirectly, in whole or in part, in or into the United States NESS-ZIONA, Israel, March 04, 2024 (GLOBE NEWSWIRE) -- Vaxil Bio Ltd. (“ Vaxil ” o...
Not for distribution to United States newswire services or for release publication, distribution or dissemination directly, or indirectly, in whole or in part, in or into the United States NESS-ZIONA, Israel, Jan. 10, 2024 (GLOBE NEWSWIRE) -- Vaxil Bio Ltd. (“ Vaxil ” or...
NESS-ZIONA, Israel, Aug. 02, 2023 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (" Vaxil " or the " Company ") (TSX VENTURE:VXL), an innovative immunotherapy biotech company specializing in cancer and infectious diseases announces the follow update on its research activities and changes in seni...
Not for distribution by US newswire or in United States NESS-ZIONA, Israel, April 24, 2023 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“ Vaxil ” or the “ Company ”) (TSX VENTURE: VXL), an innovative immunotherapy biotech company specializing in cancer and infecti...
The Digital Issue of the Summer 2020 MicroCap Review Magazine, The Official Magazine for the MicroCap Stock Market, can be read on www.StockNewsNow.com LOS ANGELES, CA / ACCESSWIRE / August 11, 2020 / SNN Incorporated, a global multimedia financial news and publishing company focuse...
News, Short Squeeze, Breakout and More Instantly...
Not for distribution to United States newswire services or for release publication, distribution or dissemination directly, or indirectly, in whole or in part, in or into the United States NESS-ZIONA, Israel, March 04, 2024 (GLOBE NEWSWIRE) -- Vaxil Bio Ltd. (“ Vaxil ” o...
Not for distribution to United States newswire services or for release publication, distribution or dissemination directly, or indirectly, in whole or in part, in or into the United States NESS-ZIONA, Israel, Jan. 10, 2024 (GLOBE NEWSWIRE) -- Vaxil Bio Ltd. (“ Vaxil ” or...
NESS-ZIONA, Israel, Aug. 02, 2023 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (" Vaxil " or the " Company ") (TSX VENTURE:VXL), an innovative immunotherapy biotech company specializing in cancer and infectious diseases announces the follow update on its research activities and changes in seni...